Patients with triple negative breast cancer and high immune cell (TILs) counts in their tumors have better survival rates even without chemotherapy. Study by MarleenKokLab highlights that these TILs are key in predicting recovery ➡️ nki.nl/news-events/ne… #BreastCancer #Research

Two weeks to #ESMO24. Multiple important breast onc trials readouts across disease subtypes, including OS from KN522, DB12, 4y of NATALEE, CAPItello290, phase 1 studies of novel ADCs, IO, targeted drugs, and so much more. The countdown is on. See you soon in Barcelona! 🇪🇸 #bcsm

Thanks OncoAlert for highlighting our research on neoadjuvant chemo for stage I TNBC MarleenKokLab . See you in Barcelona! #ESMO2024

Brilliant registry study by Manon de Graaf, looking at outcomes for pts with stage I TNBC receiving NACT. pCR rate 57%, associated w/ improved OS (5% 4y delta). Unclear benefit of adjuvant capecitabine. Potential role for ADCs to improve outcomes in this highly incident disease?

Young talent Manon de Graaf from The Netherlands Cancer Institute MarleenKokLab presenting data on patients with stage 1 TNBC. Good registries 🙏 to IKNL allow for analysis of populations excluded from most trials! #ESMO24 #ESMOAmbassadors #YOC

Thanks ACIR for putting our work on neoadjuvant immunotherapy for TNBC in the spotlight Rianne Rolfes Manon de Graaf @DiLa_lab Nature Medicine

Wrapped up #CCESummSchool24 with fantastic talks on Tumor Microenvironment, Advanced Therapies & Sexual Dimorphism Congrats to Verena Handl Med Uni Graz, Marika Reinius CRUK Cambridge Centre, Manon de Graaf The Netherlands Cancer Institute for Best Posters & Simon Linder NCT Heidelberg for Best Participant Talk 👏

Excited to present 🎤 first data #SABCS24 from TONIC2. Follow-up from nature.com/articles/s4159…. Are immune induction with dox or cisplatin indeed benefiting pts? Veerle Geurts at P1-7-30 and new data on acquired resist🔬 to aPD1 at PS17-09 The Netherlands Cancer Institute OncoAlert Nature Medicine

🏆Congratulations to Manon de Graaf The Netherlands Cancer Institute for winning a Molecular Oncology prize at the 2024 Cancer Core Europe Summer School, with her poster "In-depth spatial characterisation of the immune landscape in patients with early stage TNBC treated with immune checkpoint blockade"👏